Skip to main content
Clinical Trials/CTRI/2008/091/000061
CTRI/2008/091/000061
Recruiting
Phase 3

Randomized control trial (RCT) of Radiofrequency Ablation (RFA) and Percutaneous acetic acid (PAI) for the Treatment of Hepatocellular Carcinoma in Patients of Cirrhosis

Subrat Acharya0 sites74 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Subrat Acharya
Enrollment
74
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Subrat Acharya

Eligibility Criteria

Inclusion Criteria

  • Childâ??s A or B cirrhosis with liver mass.
  • Number of liver masses not more than 5 and the size of each \<5cm in diameter.
  • No extrahepatic disease.
  • Absence of malignant portal vein thrombosis.
  • Platelet count more than 70,000/mm3
  • Prothrombin time more than 50%.
  • Written consent of patient.

Exclusion Criteria

  • Childsâ??C cirrhosis with liver mass.
  • Liver mass \>5cm in diameter.
  • Number of liver masses more than 5\.
  • Peripherally located masses with no hepatic parenchyma around
  • Liver mass not discernable on ultrasound.
  • Extra hepatic disease like RP adenopathy, distant metastasis.
  • Coagulation disorders.
  • Unwilling patient

Outcomes

Primary Outcomes

Not specified

Similar Trials